· Education · Education Desk
Mechanism, FDA approval history for HIV-associated lipodystrophy, purity standards, and how tesamorelin compares to sermorelin and ipamorelin — relevant context for the broader RFK Jr. peptide reclassification debate.
This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.
For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.